MaxCyte (GB:MXCT) has released an update.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
MaxCyte, Inc. has reported a significant change in share ownership, with investment giant BlackRock, Inc. notifying the acquisition of additional voting rights, reaching a total of 8.42% of the voting rights in MaxCyte as of May 16, 2024. This marks an increase from the previous notification, where BlackRock held 8.32% of the voting rights in the company. The financial community is keenly observing these shifts as BlackRock’s movements in the market could signal strategic positions and influence MaxCyte’s stock.
For further insights into GB:MXCT stock, check out TipRanks’ Stock Analysis page.